Your browser doesn't support javascript.
Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso.
Kaboré, Mikaila; Sondo, Kongnimissom Apoline; Dahourou, Désiré Lucien; Cissoko, Yacouba; Konaté, Issa; Zaré, Abdoulaye; Bicaba, Brice; Ouedraogo, Boukary; Barro, Hermann; Diendéré, Eric Arnaud; Asamoah, Isabella; Damoue, Sandrine Nadège; Siri, Baperman Abdel Aziz; Diallo, Ismael; Puplampu, Peter; Poda, Armel G; Toloba, Yacouba; Dao, Sounkalo; Ouédraogo, Martial; Kouanda, Seni.
  • Kaboré M; Infectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
  • Sondo KA; Infectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
  • Dahourou DL; Training and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
  • Cissoko Y; Department of Biomedical and Public Health, Research Institute of Health Sciences, Bobo Dioulasso, Burkina Faso.
  • Konaté I; Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Zaré A; Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Bicaba B; Infectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
  • Ouedraogo B; Ministry of Health, Ouagadougou, Burkina Faso.
  • Barro H; Ministry of Health, Ouagadougou, Burkina Faso.
  • Diendéré EA; Ministry of Health, Ouagadougou, Burkina Faso.
  • Asamoah I; Training and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
  • Damoue SN; Infectious Diseases Unit, Department of Medicine, Korle-Bu Teaching Hospital, Accra, Ghana.
  • Siri BAA; Ministry of Health, Ouagadougou, Burkina Faso.
  • Diallo I; Ministry of Health, Ouagadougou, Burkina Faso.
  • Puplampu P; Training and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
  • Poda AG; Infectious Diseases Unit, Department of Medicine, Korle-Bu Teaching Hospital, Accra, Ghana.
  • Toloba Y; Department of Infectious Diseases, Souro Sanon Teaching Hospital, Bobo-Dioulasso, Burkina Faso.
  • Dao S; Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Ouédraogo M; Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Kouanda S; Training and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
Front Public Health ; 10: 743248, 2022.
Article in English | MEDLINE | ID: covidwho-1731860
ABSTRACT

BACKGROUND:

To limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso.

METHODS:

A prospective cohort study was performed using data from passengers arriving at the airport from April 9 to August 31, 2020. The data was extracted from the District Health Information Software 2 (DHIS2) platform. Cox regression was used to identify predictors of imported cases of COVID-19.

RESULTS:

Among 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The incidence rate was 1.9 cases per 1,000 traveler-days (95%CI 1.6-2.2 per 1,000). Passengers arriving in April (Adjusted hazard ratio [aHR] = 3.56; 95%CI 1.62-7.81) and May (aHR = 1.92; 95% CI 1.18-3.12) were more at risk of being tested positive compared to those arriving in August, as well as, passengers presenting with one symptom (aHR = 3.71; 95% CI 1.63-8.43) and at least two symptoms (aHR = 10.82; 95% CI 5.24-22,30) compared to asymptomatic travelers.

CONCLUSIONS:

The incidence of imported cases was relatively low in Burkina Faso between April and August 2020. The period of travel and the presence of symptoms at arrival predicted the risk of being tested positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is essential in the context of the high circulation of virus variants worldwide and the low local capacity to perform genotyping tests to strengthen the surveillance and screening capacities at the points of entry into the country.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Front Public Health Year: 2022 Document Type: Article Affiliation country: Fpubh.2022.743248

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Front Public Health Year: 2022 Document Type: Article Affiliation country: Fpubh.2022.743248